The shares were issued after a capital increase from the company’s own funds resolved at the Annual General Meeting on 12 June 2026 and entered in the Commercial Register on 28 July 2026.
Leo International Precision Health AG said Mr Leo Wang, a member of the administrative or supervisory body, received an allocation of 78,844,000 bonus shares under a capital increase from the company’s own funds. The measure was resolved at the issuer’s Annual General Meeting on 12 June 2026 and entered in the Commercial Register on 28 July 2026. The notification, transmitted by GlobeNewswire on 03 Aug 2026 at 11:30 CET/CEST, was filed as an initial notification of transactions by a person discharging managerial responsibilities. The financial instrument is a share with ISIN DE0005490601, the transaction took place outside a trading venue, and the price and volume were listed as not numerable.